Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Briviact® (brivaracetam) – Expanded indication
May 14, 2018 - UCB announced the FDA approval of Briviact (brivaracetam) tablets and oral solution, for the treatment of partial-onset seizures in patients 4 years of age and older.
